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THE EFFECTS OF CANNABINOIDS ON CHONDROCYTE 
NITRIC OXIDE PRODUCTION AND CARTILAGE PROTEO- 
GLYCAN BREAKDOWN 
K.D. Rainsford, N. Scheinkonig, R.A.D. Bunning 
Division of Biomedical Sciences and Biomedical Research 
Centre, Sheffield Hallain University, Sheffield UK 
Aim: The aim of this study was to determine whether cannabi- 
noids have direct effects on chondrocyte nitric oxide production 
and cartilage proteoglycan breakdown which may be chon- 
droprotective. 
Methods: The effects of cannabinoids anandamide and R-(+)-win 
55, 212-2 (win-55), both agonists of cannabinoid receptors CB1 
and CB2, were studied on chondrocyte nitric oxide (NO) produc- 
tion and cartilage proteoglycan breakdown. Bovine articular 
chondrocytes were used to study NO production. These were 
prepared by sequential enzymic digestion and plated directly into 
24-well plates at high density (2 x 105/cm2). After 5 days they 
were incubated with win-55 (0.01 -- 10 ;LM) or anandamide (1- 
100 XM) in the presence or absence of interleukin lc~ (IL-lc~) 
(100U/ml) for 48h. NO production was determined in culture 
media using the Greiss reaction. Cartilage proteoglycan break- 
down was determined using cultured bovine nasal cartilage 
explants, unstimulated or stimulated to resorb with IL-la 
(500U/ml) in the presence or absence of win-55 (10-100 ~.M). 
Results: Both anandamide and win-55 inhibited IL-1 stimulated 
NO production, win-55 being the more potent inhibitor producing 
inhibition at 1-10 mM compared with 50-100 mM for anan- 
damide. Preliminary studies have also shown inhibition of IL-1 
stimulated cartilage proteoglycan breakdown by win-55 at 10 and 
100 ~.M. 
Conclusions: Our studies indicate that cannabinoids may be 
chondroprotective, possibly in part by inhibition of NO produc- 
tion. Other workers have previously shown anti-arthritic effects of 
cannabinoids in animal models of arthritis which our observations 
suggest could be mediated by effects on chondrocyte metabo- 
lism. 
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THE FATE OF ORAL GLUCOSAMINE TRACED BY 13C- 
LABELING IN THE DOG 
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Interest in new therapies for arthritis is timely and the research for 
chondroprotective agents is the subject of many studies. 
Amongst the most notable is glucosamine (GIcN) (i.e. glu- 
cosamine-SO 4, glucosaniine-HCI) with the variety of studies 
demonstrating efficacy at modulating chondrocyte function and 
joint pathology. It has remained ambiguous as to whether ingest- 
ed GLcN makes its way to the joint. We built on our recent in vitro 
experiments (A&R 44:1089-1095), showing that cartilage xplants 
13 GIcN result in the detechon of cultured in medium containing C- " ' 
13C in galactosarnine moieties of chondroitin sulfate. We 
designed a study to trace the fate of orally dosed GIcN in the dog 
using 13C-GIcN and the sensitive techniques of inductively cou- 
pled plasma mass spectroscopy (ICP-MS) and NMR spec- 
troscopy. Two dogs were treated with 13C-glucosamine-HCL by 
oral dosing (combined with food). Dog 1 was given 500 
mg/dog/day (-50 mg/kg/day) for 2 weeks and dog 2, 250 
mg/dog/day for 3 weeks. Cartilage was harvested from the 
femoral condyles, along with liver, spleen, heart, kidney, skin, 
skeletal muscle, lung, and costal cartilage (treated and control 
S41 
dogs). Tissues were prepared for ICP-MS (Perkin;Eliner E~n 
6000) by digestion with nitric acid and analyzed for J~C and ~°C 
in triplicate (identical to 0.01%). The articular cartilage from dog 1 
(high dose) showed an increase of 2.6% of 13 C compared with 
control and dog 2 (low dose) an increase of 1.6%. These data 
were confirmed by NMR spectroscopy where all five peaks in the 
anomeric region of 13 C NMR spectra (G1 cUA and GalNac peaks 
from chondroitin sulfate(CS)-4 and CS-6 and keratan sulfate, 
respectively) were all elevated in both treated ogs compared to 
controls. The 12C/13 C ratios of other tissues were analyzed to 
determine the distribution of 13C_G1cN. As expected, the liver 
had the highest 13 C percentage of the other tissues but all were 
less than articular cartilage. Considering the natural stability of 
12C/13C ratios, rate of biosynthesis, and the single 13C per 
GlcN, the increases are well within the expected range if 13C- 
G1 cN was incorporated into proteoglycans. These results for the 
first time provide convincing evidence that oral GtcN is bioavail- 
able to chondrocytes in joint cartilage thereby potentially having 
an affect on the available GIcN for proteoglycan biosynthesis. 
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MITOCHONDRIAL RESPIRATORY ACTIVITY IS ALTERED IN 
OA HUMAN ARTICULAR CHONDROCYTES: 
A NEW APPROACH TO UNDERSTAND OA 
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Introduction: Osteoarthritis (OA) is associated with matrix degra- 
dation, nitric oxide (NO) production and chondrocyte death by 
apoptosis. Increasing lines of evidence suggest a key role for 
mitochondria in apoptosis and ageing. 
Aims: To analyze the biochemical parameters to define the 
Activity of Mitochondrial Respiratory Chain Complexes (AMRCC) 
in human chondrocytes from normal and OA cartilage. To study 
the aged-related changes on AMRCC and to examine the effect 
of NO on AMRCC. 
Materials and Methods: Nineteen normal and 53 OA cartilages 
were used (ages: 40-90 years). The activities of NADH CoQ oxi- 
doreductase (Complex I), succinate dehydrogenase (Complex II), 
Docylubiquinol: ferricytochrome c oxidoreductase (Complex III), 
cytochrome coxidase (Complex IV) and citrate synthase were 
measured using Beckman DU-650 spectrophotometer to monitor 
the reduction of ferricyanide (Complex I), 2,6-dichlorophenolin- 
dophenol (Complex ]1), cytochrome c (Complex III), oxidation of 
cytochrome c (Complex IV) and appearance of free coenzyme A 
(citrate synthase). Variation on mitochondrial membrane potential 
was measured by 5,5', 6, 6'-tetracholoro-l,l ', 3, 3'- 
tetraethylbenzimidazole carbocyanide iodide (JC- I) using flow 
cytometry. Statistic analysis was carried out using U-Mann 
Whitney and Pearson's tests. 
Results: tn base on citrate synthase activity, OA chondrocytes 
have more mitochondrias than normal chondrocytes (13.6%). 
However, the AMRCC is altered on OA chondrocytes. The activi- 
ty of complex II is decreased by 3 7.6% in OA cells with regard to 
normal cells. These differences between OA and normal cells are 
independent of age. A comparative analysis by classes of age 
from 40 to 70 and from 70 to 90 between normal and OA chon- 
drocytes shows a reduction in activity of complex II (about 37%). 
The analysis of correlation between ageing and mitochondrial 
activity on normal and OA chondrocytes did not show any signif- 
icant association. The administration of NO as Sodium 
NitroPrusside (SNP), causes a reduction in activity of complex 11 
(32.8%) and IV (25.5%) on normal chondrocytes. Furthermore, 
NO decreases the mitochondriat membrane potential by a 24% 
quantified by flow cytometry. 
$42 
Conclusions: These findings suggest that the alteration of com- 
plex II activity may contribute to pathological process in OA. NO 
is involved in pathological development of OA because it modi- 
fies the mitochondrial respiratory activity and induces a mito- 
chondril depolarization. 
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DIFFERENTIAL REGULATION OF CONNECTIVE TISSUE 
GROWTH FACTOR mRNA LEVELS BY TRANSFORMING 
GROWTH FACTOR-P AND TUMOUR NECROSIS FACTOR-c¢ 
IN CANINE ARTICULAR CHONDROCYTES 
S Richardson, SD Carter 
Connective 77ssue Research Group, Dept of Veterinary 
Pathology, University of Liverpool, Liverpool, UK 
Aim: The aim of this study was to investigate the effects of TGF- 
and TNF-c~ on expression of CTGF by normal canine articular 
chondrocytes maintained in alginate culture. 
Methods: Cartilage was obtained post-mortem from normal 
canine stifle joints. Chondrocytes were isolated by collagenase 
digestion, cultured to second passage in monolayer and trans- 
ferred to alginate. Alginate embedded chondrocytes were stimu- 
lated with a range of doses of TGFb (0.2 - 25nglml) and TNF-c~ (2 
- 250ng/ml), either singly or in combination for 24 hours. Canine 
specific CTGF primers were used in RT-PCR to examine mRNA 
expression. 
Results: CTGF mRNA was constitutively expressed by canine 
chondrocytes and was significantly upregulated by TGF-I~, while 
TNF-c~ caused a significant decrease. Changes were found to be 
dose-dependant and costimulation showed an antagonistic rela- 
tionship between the two cytokines. 
Conclusion: We showed CTGF mRNA to be expressed by nor- 
mal canine articular chondrocytes and that its expression can be 
modulated by both the anabolic growth factor TGF-~ and the 
catabolic cytokine TNF-(z. While both TGF-~ and TNF-a have 
been shown to modulate CTGF expression in fibroblasts, there is 
no published data on its regulation in articular chondrocytes. As 
a downstream effector of TGF-J3 action CTGF offers a potential 
therapeutic target in OA as increased expression could both stim- 
ulate ECM component production and inhibit catabolic enzyme 
synthesis. 
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SUSCEPTIBILITY OF OA CARTILAGE TO THE EFFECTS OF 
IL-lb ARE NOT RELATED TO EXPRESSION OF EITHER THE 
TYPE I OR TYPE II |L-1B RECEPTOR 
Srinivasan MS, Elson CJ 
Westacott C/. University of Bristol Medical School, Bristol, UK 
Introduction: Whether IL-I~ contributes to the focal loss of car- 
tilage characteristic of osteoarthritis (OA) is not clear. The sus- 
ceptibility of cartilage from different regions of OA knee joints to 
the effects of IL-I and its relationship with chondrocyte xpres- 
sion of type I, signaling, and type II, decoy, IL-113 receptors (R) 
was therefore xamined. 
Methods: Cartilage was obtained from different regions on the 
knees of II OA patients undergoing surgery for total knee replace- 
ment (1) and incubated for 14 days with IL-I~ (2Opg/ml). 
Chondrocytes were isolated by enzymatic digestion from carti- 
lage off-cuts obtained from each region (1). Chondrocytes and 
HEL92 ceils, used as a positive control for IL-1 R, were stained 
with non-crossreacting antibodies to type 1 or type II IL-1R 
(Genzyine) and II.-1 R expression determined by flow cytometry. 
Results: Significant regional variation was observed in suscepti- 
bility to the effects of IL-1. Differences were apparent in chon- 
drocyte expression of the two receptor types; IL-1RI and IL-1RII 
expression was related. 
Table L IL-JR expression on chondrocytes isolated from OA car- 
tilage 
Expression IL-1RJ U-IRII P value Correlation 
Proportion 
Of cells (%) 2.4±0.6 10.9±1.3 P<0.001 R=0.53, 
p=O.005 
R/cell 461 +144 1468±396 P<0.001 R=0.39, 
p=O.013 
No significant correlation was found between GAG loss from 
cartilage and_expression of either IL-1RI or IL-1RII on chondro- 
cytes. 
Table 2. Relationship between GAG loss and IL-JR expression 
IL-1RI IL-IRII 
Proportion of cells (%) R-0.069, p=0.077 r=0.096, p=0.559 
R/cell R=0. 11, p=0.505 r=0.093, p=0.573 
Discussion: Significant regional differences in cartilage suscepti- 
bility to the effects of IL-I were found. However, the absence of 
any significant relationship between the IL-IR expression and IL- 
1b-induced GAG release from cartilage suggests that factors 
other than chondrocyte receptor expression influence the 
response of cartilage to the effects of this cytokine. 
Reference 
1. Webb et al., (1997) Osteoarthritis Cartilage, 5: 427. 
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BY REACTIVE OXYGEN SPECIES AND NITRIC OXIDE IN 
HUMAN ARTICULAR CHONDROCYTES 
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Aim: To assess the effects of two antioxidants, N-monomethyl-L- 
arginine (LNMMA) and N-acetylcysteine (NAC) on the expression 
of TGF-~I, 132 and 133 and their receptors I and il, using LPS-treat- 
ed human chondrocytes. 
Methods: Human chondrocytes were treated for 48h with LPS 
(10 Zg/ml), L-NMMA (0.5 mM) or NAC (1 mM). Nitrite levels were 
assayed using the Griess method. The expression of NO syn- 
thase (iNOS), TGF-131, 132, 133, TGF-13-.RI and II, was determined 
by semi-quantitative RT-PCR. 
Results: LPS induced a dramatic increase of both NO and iNOS 
mRNA levels. L-NMMA abolished NO production without affect- 
ing iNOS mRNA levels. In contrast, NAC strongly synergized with 
LPS to stimulate NO synthesis. LPS did not significantly alter 
TGF-I31 expression whereas L-NMMA inhibited its production. 
TGF-132 mRNA level was decreased by LPS and was not changed 
by L-NMMA. On the other hand, NAC counteracted the LPS- 
induced inhibition of TGF-b2 expression. TGF-b3 mRNA level 
was markedly reduced by LPS alone, or with both LoNMMA and 
NAC. TGF-~RI expression was slightly increased by the combi- 
nation LPS+L-NMMA or LPS+NAC whereas that of TGF~-RII was 
reduced in these conditions. 
Conclusions: ROS differentially control the TGF-I] system, 
depending on the isoform: TGF-I31 mRNA level depends on NO 
whereas that of TGF-132 is regulated by ROS and TGF-133 seems 
